Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-08 10:17 am Sale | 13G | Phillips Edison & Company Inc. PECO | WELLINGTON MANAGEMENT GROUP LLP | 8,083,622 6.76% | -1,154,884 (-12.50%) | View |
2024-02-08 10:17 am Sale | 13G | Primoris Services Corp PRIM | WELLINGTON MANAGEMENT GROUP LLP | 1,558,081 2.92% | -2,299,076 (-59.61%) | View |
2024-02-08 10:17 am Sale | 13G | PROASSURANCE CORP PRA | WELLINGTON MANAGEMENT GROUP LLP | 2,777,882 5.45% | -660,443 (-19.21%) | View |
2024-02-08 10:17 am Purchase | 13G | RayzeBio Inc. RYZB | WELLINGTON MANAGEMENT GROUP LLP | 3,504,409 5.74% | 3,504,409 (New Position) | View |
2024-02-08 10:17 am Sale | 13G | Regional Management Corp. RM | WELLINGTON MANAGEMENT GROUP LLP | 731,018 7.43% | -62,413 (-7.87%) | View |
2024-02-08 10:17 am Purchase | 13G | Revolution Medicines Inc. RVMD | WELLINGTON MANAGEMENT GROUP LLP | 14,882,086 9.09% | 662,656 (+4.66%) | View |
2024-02-08 10:17 am Purchase | 13G | ROCKET PHARMACEUTICALS INC. RCKT | WELLINGTON MANAGEMENT GROUP LLP | 8,197,546 9.09% | 4,690,529 (+133.75%) | View |
2024-02-08 10:17 am Sale | 13G | SAGE THERAPEUTICS INC SAGE | WELLINGTON MANAGEMENT GROUP LLP | 6,061,996 10.1% | -301,634 (-4.74%) | View |
2024-02-08 10:17 am Purchase | 13G | Shockwave Medical Inc. SWAV | WELLINGTON MANAGEMENT GROUP LLP | 2,500,594 6.78% | 2,500,594 (New Position) | View |
2024-02-08 10:17 am Purchase | 13G | Shoals Technologies Group Inc. SHLS | WELLINGTON MANAGEMENT GROUP LLP | 12,910,322 7.59% | 12,910,322 (New Position) | View |
2024-02-08 10:17 am Sale | 13G | SITIO ROYALTIES CORP COM C STR | WELLINGTON MANAGEMENT GROUP LLP | 4,868,385 5.95% | -601,072 (-10.99%) | View |
2024-02-08 10:17 am Sale | 13G | Sovos Brands Inc. SOVO | WELLINGTON MANAGEMENT GROUP LLP | 1,352,465 1.33% | -4,865,667 (-78.25%) | View |
2024-02-08 10:17 am Purchase | 13G | Sprout Social Inc. SPT | WELLINGTON MANAGEMENT GROUP LLP | 3,555,941 7.29% | 2,686,892 (+309.18%) | View |
2024-02-08 10:14 am Purchase | 13G | HELIOS TECHNOLOGIES INC. HLIO | WELLINGTON MANAGEMENT GROUP LLP | 2,524,041 7.64% | 2,524,041 (New Position) | View |
2024-02-08 10:14 am Sale | 13G | ICU MEDICAL INC ICUI | WELLINGTON MANAGEMENT GROUP LLP | 1,575,456 6.53% | -790,930 (-33.42%) | View |
2024-02-08 10:14 am Sale | 13G | Inari Medical Inc. NARI | WELLINGTON MANAGEMENT GROUP LLP | 4,563,325 7.92% | -375,249 (-7.60%) | View |
2024-02-08 10:14 am Purchase | 13G | Ingevity Corp NGVT | WELLINGTON MANAGEMENT GROUP LLP | 2,148,379 5.93% | 1,006,279 (+88.11%) | View |
2024-02-08 10:14 am Sale | 13G | INSULET CORP PODD | WELLINGTON MANAGEMENT GROUP LLP | 3,401,606 4.87% | -2,300,422 (-40.34%) | View |
2024-02-08 10:14 am Sale | 13G | Intra-Cellular Therapies Inc. ITCI | WELLINGTON MANAGEMENT GROUP LLP | 1,763,475 1.83% | -3,646,210 (-67.40%) | View |
2024-02-08 10:14 am Purchase | 13G | Jamf Holding Corp. JAMF | WELLINGTON MANAGEMENT GROUP LLP | 7,871,450 6.26% | 860,788 (+12.28%) | View |